{"id":"https://openalex.org/W4206040468","doi":"https://doi.org/10.1177/03008916211067568","title":"Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trial","display_name":"Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trial","publication_year":2022,"publication_date":"2022-01-06","ids":{"openalex":"https://openalex.org/W4206040468","doi":"https://doi.org/10.1177/03008916211067568","pmid":"https://pubmed.ncbi.nlm.nih.gov/34989265"},"language":"en","primary_location":{"id":"doi:10.1177/03008916211067568","doi":"https://doi.org/10.1177/03008916211067568","is_oa":false,"landing_page_url":"https://doi.org/10.1177/03008916211067568","pdf_url":null,"source":{"id":"https://openalex.org/S4210189328","display_name":"Tumori Journal","issn_l":"0300-8916","issn":["0300-8916","2038-2529"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tumori Journal","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4206040468"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051951830","display_name":"Benedetta Conte","orcid":"https://orcid.org/0000-0003-4720-2497","observed_orcids":["https://orcid.org/0000-0003-4720-2497"]},"institutions":[{"id":"https://openalex.org/I4210146472","display_name":"Ospedale Policlinico San Martino","ror":"https://ror.org/04d7es448","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210146472","https://openalex.org/I4210153126","https://openalex.org/I4405264730"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Benedetta Conte","raw_affiliation_strings":["Department of Medical Oncology, Breast Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy"],"raw_orcid":"https://orcid.org/0000-0003-4720-2497","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Breast Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy","institution_ids":["https://openalex.org/I4210146472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030013928","display_name":"Filippo Montemurro","orcid":"https://orcid.org/0000-0003-4231-2291","observed_orcids":["https://orcid.org/0000-0003-4231-2291"]},"institutions":[{"id":"https://openalex.org/I4210151091","display_name":"Candiolo Cancer Institute","ror":"https://ror.org/04wadq306","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210151091","https://openalex.org/I4210153126","https://openalex.org/I4210167100"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Filippo Montemurro","raw_affiliation_strings":["Multidisciplinary Outpatient Oncology Clinic, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Multidisciplinary Outpatient Oncology Clinic, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy","institution_ids":["https://openalex.org/I4210151091"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013062135","display_name":"Alessia Levaggi","orcid":"https://orcid.org/0000-0003-1007-9173","observed_orcids":["https://orcid.org/0000-0003-1007-9173"]},"institutions":[{"id":"https://openalex.org/I4210146472","display_name":"Ospedale Policlinico San Martino","ror":"https://ror.org/04d7es448","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210146472","https://openalex.org/I4210153126","https://openalex.org/I4405264730"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Alessia Levaggi","raw_affiliation_strings":["Department of Medical Oncology, Breast Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Breast Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy","institution_ids":["https://openalex.org/I4210146472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022289263","display_name":"Eva Blondeaux","orcid":"https://orcid.org/0000-0001-9566-4579","observed_orcids":["https://orcid.org/0000-0001-9566-4579"]},"institutions":[{"id":"https://openalex.org/I4210146472","display_name":"Ospedale Policlinico San Martino","ror":"https://ror.org/04d7es448","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210146472","https://openalex.org/I4210153126","https://openalex.org/I4405264730"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Eva Blondeaux","raw_affiliation_strings":["Department of Medical Oncology, Breast Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Breast Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy","institution_ids":["https://openalex.org/I4210146472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072581506","display_name":"Chiara Molinelli","orcid":"https://orcid.org/0000-0001-7167-3868","observed_orcids":["https://orcid.org/0000-0001-7167-3868"]},"institutions":[{"id":"https://openalex.org/I4210146472","display_name":"Ospedale Policlinico San Martino","ror":"https://ror.org/04d7es448","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210146472","https://openalex.org/I4210153126","https://openalex.org/I4405264730"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Chiara Molinelli","raw_affiliation_strings":["Department of Medical Oncology, Breast Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Breast Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy","institution_ids":["https://openalex.org/I4210146472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012073722","display_name":"B\u00e1rbara Cardinali","orcid":"https://orcid.org/0000-0002-3191-4388","observed_orcids":["https://orcid.org/0000-0002-3191-4388"]},"institutions":[{"id":"https://openalex.org/I4210146472","display_name":"Ospedale Policlinico San Martino","ror":"https://ror.org/04d7es448","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210146472","https://openalex.org/I4210153126","https://openalex.org/I4405264730"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Barbara Cardinali","raw_affiliation_strings":["Department of Medical Oncology, Breast Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Breast Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy","institution_ids":["https://openalex.org/I4210146472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008306424","display_name":"Francesca Benedetta Poggio","orcid":"https://orcid.org/0000-0002-4518-2827","observed_orcids":["https://orcid.org/0000-0002-4518-2827"]},"institutions":[{"id":"https://openalex.org/I4210146472","display_name":"Ospedale Policlinico San Martino","ror":"https://ror.org/04d7es448","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210146472","https://openalex.org/I4210153126","https://openalex.org/I4405264730"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Francesca Poggio","raw_affiliation_strings":["Department of Medical Oncology, IRCCS Ospedale Policlinico San Martino, Genova, U.O. Oncologia Medica 2, Genova, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, IRCCS Ospedale Policlinico San Martino, Genova, U.O. Oncologia Medica 2, Genova, Italy","institution_ids":["https://openalex.org/I4210146472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075500641","display_name":"Giulia Buzzatti","orcid":"https://orcid.org/0000-0003-0077-7795","observed_orcids":["https://orcid.org/0000-0003-0077-7795"]},"institutions":[{"id":"https://openalex.org/I4210146472","display_name":"Ospedale Policlinico San Martino","ror":"https://ror.org/04d7es448","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210146472","https://openalex.org/I4210153126","https://openalex.org/I4405264730"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giulia Buzzatti","raw_affiliation_strings":["Department of Medical Oncology, IRCCS Ospedale Policlinico San Martino, Genova, U.O. Oncologia Medica 2, Genova, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, IRCCS Ospedale Policlinico San Martino, Genova, U.O. Oncologia Medica 2, Genova, Italy","institution_ids":["https://openalex.org/I4210146472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020297889","display_name":"Claudia Bighin","orcid":"https://orcid.org/0000-0001-9956-0216","observed_orcids":["https://orcid.org/0000-0001-9956-0216"]},"institutions":[{"id":"https://openalex.org/I4210146472","display_name":"Ospedale Policlinico San Martino","ror":"https://ror.org/04d7es448","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210146472","https://openalex.org/I4210153126","https://openalex.org/I4405264730"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Claudia Bighin","raw_affiliation_strings":["Department of Medical Oncology, Breast Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Breast Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy","institution_ids":["https://openalex.org/I4210146472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082293621","display_name":"Matteo Lambertini","orcid":"https://orcid.org/0000-0003-1797-5296","observed_orcids":["https://orcid.org/0000-0003-1797-5296"]},"institutions":[{"id":"https://openalex.org/I4210146472","display_name":"Ospedale Policlinico San Martino","ror":"https://ror.org/04d7es448","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210146472","https://openalex.org/I4210153126","https://openalex.org/I4405264730"]},{"id":"https://openalex.org/I83816512","display_name":"University of Genoa","ror":"https://ror.org/0107c5v14","country_code":"IT","type":"education","lineage":["https://openalex.org/I83816512"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Matteo Lambertini","raw_affiliation_strings":["Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genoa, Genoa, Italy","Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genoa, Genoa, Italy","institution_ids":["https://openalex.org/I83816512"]},{"raw_affiliation_string":"Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy","institution_ids":["https://openalex.org/I4210146472"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5074479074","display_name":"Lucia Del Mastro","orcid":"https://orcid.org/0000-0002-9546-5841","observed_orcids":["https://orcid.org/0000-0002-9546-5841"]},"institutions":[{"id":"https://openalex.org/I4210146472","display_name":"Ospedale Policlinico San Martino","ror":"https://ror.org/04d7es448","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210146472","https://openalex.org/I4210153126","https://openalex.org/I4405264730"]},{"id":"https://openalex.org/I83816512","display_name":"University of Genoa","ror":"https://ror.org/0107c5v14","country_code":"IT","type":"education","lineage":["https://openalex.org/I83816512"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Lucia Del Mastro","raw_affiliation_strings":["Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genoa, Genoa, Italy","Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genoa, Genoa, Italy","institution_ids":["https://openalex.org/I83816512"]},{"raw_affiliation_string":"Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy","institution_ids":["https://openalex.org/I4210146472"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5074479074"],"corresponding_institution_ids":["https://openalex.org/I4210146472","https://openalex.org/I83816512"],"apc_list":{"value":3500,"currency":"USD","value_usd":3500},"apc_paid":null,"fwci":0.3212,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.50228103,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"109","issue":"1","first_page":"71","last_page":"78"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.6836000084877014,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.6836000084877014,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.28760001063346863,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.00930000003427267,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9919999837875366},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.9649999737739563},{"id":"https://openalex.org/keywords/anthracyclines","display_name":"anthracyclines","score":0.8349999785423279},{"id":"https://openalex.org/keywords/taxanes","display_name":"taxanes","score":0.6589999794960022},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9890000224113464},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.8259999752044678},{"id":"https://openalex.org/keywords/fec-regimen","display_name":"FEC regimen","score":0.7889999747276306},{"id":"https://openalex.org/keywords/epirubicin","display_name":"epirubicin","score":0.8349999785423279},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.921999990940094},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.9900000095367432},{"id":"https://openalex.org/keywords/pathological-complete-response","display_name":"pathological complete response","score":0.9800000190734863},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.8799999952316284},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.859000027179718},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.8370000123977661},{"id":"https://openalex.org/keywords/febrile-neutropenia","display_name":"febrile neutropenia","score":0.8450000286102295}],"concepts":[{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.873049259185791},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8264424800872803},{"id":"https://openalex.org/C2780835546","wikidata":"https://www.wikidata.org/wiki/Q425122","display_name":"Epirubicin","level":4,"score":0.816614031791687},{"id":"https://openalex.org/C2776802502","wikidata":"https://www.wikidata.org/wiki/Q417589","display_name":"Anthracycline","level":4,"score":0.7944055199623108},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6813589334487915},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.6763644218444824},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.662405252456665},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5905361771583557},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5731934309005737},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5216106176376343},{"id":"https://openalex.org/C2778292576","wikidata":"https://www.wikidata.org/wiki/Q6991934","display_name":"Neoadjuvant therapy","level":4,"score":0.5200433731079102},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.5115295648574829},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.4273241460323334},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3411003053188324},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3297469913959503},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.277058869600296}],"mesh":[{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D001952","descriptor_name":"Bridged-Ring Compounds","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013318","descriptor_name":"Stroke Volume","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015251","descriptor_name":"Epirubicin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016277","descriptor_name":"Ventricular Function, Left","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D018943","descriptor_name":"Anthracyclines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D020360","descriptor_name":"Neoadjuvant Therapy","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1177/03008916211067568","doi":"https://doi.org/10.1177/03008916211067568","is_oa":false,"landing_page_url":"https://doi.org/10.1177/03008916211067568","pdf_url":null,"source":{"id":"https://openalex.org/S4210189328","display_name":"Tumori Journal","issn_l":"0300-8916","issn":["0300-8916","2038-2529"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tumori Journal","raw_type":"journal-article"},{"id":"pmid:34989265","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34989265","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tumori","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:iris.unige.it:11567/1070940","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11567/1070940","pdf_url":null,"source":{"id":"https://openalex.org/S4377196291","display_name":"CINECA IRIS Institutial Research Information System (University of Genoa)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I83816512","host_organization_name":"University of Genoa","host_organization_lineage":["https://openalex.org/I83816512"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W1987326983","https://openalex.org/W1996778928","https://openalex.org/W2024933507","https://openalex.org/W2046958698","https://openalex.org/W2055235037","https://openalex.org/W2075894019","https://openalex.org/W2095861620","https://openalex.org/W2096884232","https://openalex.org/W2101979288","https://openalex.org/W2104337757","https://openalex.org/W2111578514","https://openalex.org/W2123591186","https://openalex.org/W2124268018","https://openalex.org/W2125239609","https://openalex.org/W2151262170","https://openalex.org/W2155560234","https://openalex.org/W2162982444","https://openalex.org/W2169351080","https://openalex.org/W2264815585","https://openalex.org/W2266198524","https://openalex.org/W2301857081","https://openalex.org/W2379981061","https://openalex.org/W2499208470","https://openalex.org/W2530010510","https://openalex.org/W2618058692","https://openalex.org/W2624590002","https://openalex.org/W2768649895","https://openalex.org/W2774227900","https://openalex.org/W2899659781","https://openalex.org/W2902218997","https://openalex.org/W2915398514","https://openalex.org/W2965526302","https://openalex.org/W2999536665","https://openalex.org/W3122861570","https://openalex.org/W3126817559","https://openalex.org/W4211123279"],"related_works":["https://openalex.org/W2588133229","https://openalex.org/W2624344611","https://openalex.org/W2117984780","https://openalex.org/W2586996246","https://openalex.org/W2078582456","https://openalex.org/W2805783389","https://openalex.org/W4386939113","https://openalex.org/W7212184939","https://openalex.org/W3031350720","https://openalex.org/W7162677758"],"abstract_inverted_index":{"Objective:":[0],"Neoadjuvant":[1],"chemotherapy":[2,54],"has":[3],"become":[4],"the":[5,16,39,44,139],"preferred":[6],"treatment":[7,59],"in":[8,43,126,159,166],"HER2-positive":[9,62,71],"early":[10],"breast":[11,63,72],"cancer.":[12,64],"Several":[13],"trials":[14],"investigated":[15],"neoadjuvant":[17,58,80],"efficacy":[18],"of":[19,41,79,104,129,136],"dual":[20],"HER2":[21],"blockade":[22],"with":[23,68,76,194,207],"anthracycline-free":[24],"chemotherapy,":[25],"whereas":[26],"few":[27],"data":[28],"are":[29],"available":[30],"on":[31],"single-agent":[32],"trastuzumab":[33,56,111,191],"and":[34,55,110,143,152,190,198],"anthracycline-based":[35,53],"regimens,":[36],"which":[37],"represent":[38],"standard":[40],"care":[42],"adjuvant":[45],"setting.":[46],"This":[47],"phase":[48],"II,":[49],"single-arm":[50],"trial":[51],"assessed":[52],"as":[57],"for":[60],"high-risk":[61],"Methods:":[65],"Forty-three":[66],"patients":[67],"stage":[69],"II\u2013III":[70],"cancer":[73],"were":[74,146],"treated":[75],"4":[77,117],"courses":[78,103],"5-fluorouracil":[81],"600":[82,92],"mg/m":[83,88,93,108],"2":[84,89,94,109,112],",":[85,90],"epirubicin":[86],"90":[87],"cyclophosphamide":[91],"(FEC":[95],"\u00d74)":[96],"every":[97],"21":[98],"days,":[99],"followed":[100,187],"by":[101,188],"12":[102],"weekly":[105],"paclitaxel":[106,189],"80":[107],"mg/Kg":[113],"IV":[114],"(loading":[115],"dose":[116],"mg/kg).":[118],"Results:":[119],"Pathologic":[120],"complete":[121],"response":[122],"(pCR)":[123],"was":[124,164,192,205],"observed":[125,165],"22":[127],"(51%)":[128],"43":[130],"patients.":[131,168],"After":[132],"a":[133],"median":[134],"follow-up":[135],"6":[137],"years,":[138],"5-year":[140],"disease-free":[141],"survival":[142,145],"overall":[144],"85.8%":[147],"(95%":[148],"confidence":[149],"interval":[150],"75.9%\u201397%)":[151],"89.6%":[153],"(80.4%\u201399.8%),":[154],"respectively.":[155],"A":[156],"temporary":[157],"decrease":[158],"left":[160],"ventricular":[161],"ejection":[162],"fraction":[163],"two":[167],"No":[169],"cardiac":[170],"death":[171],"or":[172],"congestive":[173],"heart":[174],"failure":[175],"occurred.":[176],"One":[177],"patient":[178],"died":[179],"due":[180],"to":[181],"febrile":[182],"neutropenia.":[183],"Conclusions:":[184],"FEC":[185],"\u00d74":[186],"associated":[193,206],"high":[195],"pCR":[196],"rates":[197],"favorable":[199],"long-term":[200],"outcomes.":[201],"However,":[202],"this":[203],"regimen":[204],"relevant":[208],"hematologic":[209],"toxicity.":[210]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2022-01-25T00:00:00"}
